Annex A. Science And Technology Objectives (STOs)
Army Science and Technology Master Plan (ASTMP 1997)

III.J.05. Dengue Virus Vaccines. By FY97, select the best methodology for vaccine development. By FY99, transition to advanced development a candidate polyvalent dengue virus vaccine to protect 80 percent of immunized troops from dengue fever caused by dengue virus types 1, 2, 3, and 4.

Supports: Army Modernization Plan, Medical Annex O—Project, Sustain, and Protect the Force. The Medical Threat Facing a Force Projection Army (1994). Food and Drug Administration regulatory requirements.